Harmony Biosciences Inc.
HRMY | NASDAQ
$42.06
-$0.04 (-0.10%)
Sep 22, 2026, 2:37 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 75.43M | 32.49M | 22.49M | 50.87M | 39.78M | 45.56M | 49.48M | 46.09M | 11.59M | 38.33M | 26.61M | 38.46M | 34.3M | 29.49M | 48.51M | 87.94M | 23.53M | 21.49M | 22.71M | -9.62M | 14.12M | 7.39M |
Depreciation & Amortization | 5.97M | 5.97M | 7.43M | 6.13M | 5.97M | 6.13M | 5.97M | 6.14M | 6.23M | 6.3M | 6.13M | 7.36M | 6.49M | 6.48M | 6.49M | 6.48M | 6.47M | 5.61M | 5.18M | 5.13M | 5.43M | 5.34M |
Stock-Based Compensation | 9.34M | 10.62M | 10.17M | 10.82M | 11.46M | 12.45M | 10.07M | 11.45M | 10.96M | 10.43M | 8.86M | 7.96M | 7.79M | 6.56M | 7.67M | 6.97M | 7.37M | 4.9M | 4.38M | 4.66M | 3.81M | 3.25M |
Other Working Capital | 15.48M | -49.18M | 77.3M | 40.55M | -10.61M | -7.46M | 14.42M | 23.47M | -17.43M | -11.67M | 32.6M | 10.44M | 4.77M | -1.26M | -25.45M | 36.77M | 7.52M | -5.97M | 10.62M | 2.9M | 5.48M | -3.53M |
Other Non-Cash Items | 185K | 32.18M | -2.65M | 8.81M | 15.11M | -580K | 943K | -17.04M | 34.49M | -6.19M | 2.3M | 2.58M | -4.29M | -1.08M | -10.48M | -78.02M | 142K | 6.29M | -4.09M | 29.22M | -2.63M | 2.1M |
Deferred Income Tax | -3.2M | -3.86M | 14.68M | n/a | -6.49M | n/a | -6.71M | n/a | n/a | n/a | 1.12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 4.72M | -49.63M | 74.04M | 32.1M | 13.5M | -29.58M | 15.82M | 23.86M | -20.66M | -17.74M | 31.64M | 6.75M | -7.23M | 1.11M | -25.52M | 31.83M | -3.78M | -9.43M | 9.35M | 1.03M | -2.65M | -5.55M |
Operating Cash Flow | 92.43M | 27.76M | 126.15M | 108.73M | 79.33M | 33.99M | 75.56M | 70.5M | 42.62M | 31.14M | 76.67M | 63.1M | 37.06M | 42.56M | 26.68M | 55.21M | 33.73M | 28.85M | 37.53M | 30.42M | 18.07M | 12.53M |
Capital Expenditures | n/a | n/a | -107K | -71K | -4K | -128K | -513K | -3K | -632K | -5K | -107K | n/a | -205K | n/a | n/a | -86K | -41K | -45K | n/a | -93K | -201K | -4K |
Cash Acquisitions | n/a | n/a | -19.25M | n/a | n/a | n/a | n/a | n/a | -33.07M | n/a | -44.53M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100M | n/a | n/a | n/a |
Purchase of Investments | -152.53M | -179M | -18.84M | n/a | -23.9M | n/a | -35.69M | n/a | n/a | n/a | -21.61M | n/a | n/a | -47.78M | -55.09M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 21.03M | 27.35M | 20.56M | n/a | 19.32M | n/a | 30.01M | n/a | n/a | n/a | 22.62M | n/a | n/a | 45.99M | 8.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -32M | n/a | -4.72M | -15M | 2.49M | -1M | 748K | -21.16M | -6.18M | 7.57M | -813K | -7.57M | n/a | 1 | -32.36M | -22.41M | -40M | 100M | n/a | n/a | -100M |
Investing Cash Flow | -131.5M | -183.65M | -17.63M | -4.79M | -19.59M | 2.36M | -7.19M | 745K | -54.86M | -6.19M | -36.07M | -813K | -7.77M | -1.79M | -46.9M | -32.45M | -22.45M | -40.05M | n/a | -93K | -201K | -100M |
Debt Repayment | -5M | -5M | -5M | -3.75M | -3.75M | -3.75M | -3.75M | -3.75M | -3.75M | -3.75M | -3.75M | -196.5M | -500K | -500K | -500K | -500K | -500K | -500K | -500K | -22M | n/a | n/a |
Common Stock Repurchased | -1.08M | n/a | n/a | n/a | n/a | -1.31M | n/a | n/a | -269K | n/a | -50M | -50M | -514K | n/a | n/a | n/a | n/a | n/a | n/a | 30M | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -55.26M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -2.57M | -663K | n/a | -1.03M | 4.71M | 1.01M | 2.58M | 573K | 116K | 55.49M | 191.4M | 675K | 3.91M | 3.16M | 2.55M | 1.25M | 1.88M | 7.57M | -8.31M | n/a | n/a |
Financial Cash Flow | -558K | -7.22M | -3.02M | -3M | -2.69M | -352K | -2.74M | -1.18M | -3.45M | -3.63M | -53.52M | -55.1M | -339K | 3.41M | 2.66M | 2.05M | 750K | 1.38M | 7.07M | -313K | 648K | 12K |
Net Cash Flow | -39.63M | -163.1M | 105.5M | 100.95M | 57.05M | 36M | 65.63M | 70.07M | -15.69M | 21.32M | -12.92M | 7.19M | 28.95M | 44.18M | -17.56M | 24.81M | 12.03M | -9.81M | 44.61M | 30.02M | 18.52M | -87.46M |
Free Cash Flow | 92.43M | 27.76M | 126.04M | 108.66M | 79.32M | 33.86M | 75.05M | 70.5M | 41.99M | 31.14M | 76.56M | 63.1M | 36.86M | 42.56M | 26.68M | 55.12M | 33.69M | 28.81M | 37.53M | 30.33M | 17.87M | 12.53M |
Adj. Free Cash Flow | 83.1M | 17.14M | 115.88M | 97.84M | 67.87M | 21.41M | 64.98M | 59.05M | 31.02M | 20.7M | 67.7M | 55.14M | 29.07M | 36M | 19.01M | 48.15M | 26.32M | 23.91M | 33.15M | 25.67M | 14.06M | 9.28M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | -330K | n/a | -417.01K | n/a | n/a | n/a | -42.69K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | -107K | -71K | -4K | -128K | -183K | -3K | -214.99K | -5K | -107K | n/a | -162.31K | n/a | n/a | -86K | -41K | -45K | n/a | -93K | -201K | -4K |
Owner Earnings | 92.43M | 27.76M | 126.15M | 108.73M | 79.33M | 33.99M | 75.23M | 70.5M | 42.2M | 31.14M | 76.67M | 63.1M | 37.02M | 42.56M | 26.68M | 55.21M | 33.73M | 28.85M | 37.53M | 30.42M | 18.07M | 12.53M |
Add to Watchlist
Select watchlists to add or remove HRMY